NCT05589246

Brief Summary

Funnel chest deformation is a painful procedure, which requires high doses and long time used of opioids. It makes difficult introduction of ERAS protocol. Intraoperative cryolesia of intercostal nerves serves great relief of pain after this procedures. However ablation of the nerves needs 12-24 hours to achieve effects. During this time the high doses of opioids are needed. It causes side effects (sedation makes rehabilitation difficult). On the other hand, percutaneus cryoablation performed 12-24 hours before Nuss procedure needs repeated general anaesthesia. The investigators hypothesed that regional analgesia (erector spine plain block) performed just before intraopertive cryolesia may cover time to full cryolesia effect.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 28, 2022

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 8, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 21, 2022

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

October 21, 2022

Status Verified

October 1, 2022

Enrollment Period

1 month

First QC Date

October 8, 2022

Last Update Submit

October 18, 2022

Conditions

Keywords

nuss procedure

Outcome Measures

Primary Outcomes (1)

  • The worse pain

    Maximal pain within first 24 hours after operation, Numeric pain score. Range from 0 to 10.

    within first 24 hours after operation

Secondary Outcomes (1)

  • LAST (Local anesthetic systemic toxicity)

    within first 24 hours after operation

Study Arms (2)

control

NO INTERVENTION

intraoperative cryoanalgesia of intercostal nerves with multimodal analgesia

intervention

EXPERIMENTAL

regional analgesia (ESP block) with intraoperative cryoanalgesia of intercostal nerves and multimodal analgesia

Device: regional analgesia with cryolesia

Interventions

The regional analgesia (erector spine plane block) will be added to intraoperative cryolesia of intercostal nerves

intervention

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients undergoing pectus excavatum repair with modyfied minimal invasive thoracoscopic NUSS technique
  • aged 10 years or above 10 up to 18
  • informed consent signed for cryoanalgesia informed consent signed for regional analgesia

You may not qualify if:

  • Age of 9 years or below
  • Refuse to receive cryoanalgesia or regional analgesia as primary pain relief
  • Any contraindication to cryoanalgesia
  • Difficult follow-up for geographical reasons and/or impossibility by the patient to understand how to perform self-measurements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pomeranian Medical University

Szczecin, 70-204, Poland

RECRUITING

Pomeranian Medical University

Szczecin, 71-252, Poland

RECRUITING

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jowita Biernawska, MD PhD

    Pomeranian Medical Universitet Szczecin

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jowita Biernawska, MD PhD

CONTACT

Sławomir Zacha, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 8, 2022

First Posted

October 21, 2022

Study Start

September 28, 2022

Primary Completion

November 1, 2022

Study Completion

December 1, 2022

Last Updated

October 21, 2022

Record last verified: 2022-10

Locations